Press Releases DiaSorin S.p.A.

Equities

DIA

IT0003492391

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-06-10 am EDT			Pre-market 02:42:00 am
99.86 ^EUR	0.00%		100.1	+0.24%

Jun. 05	Mib up at start, DiaSorin good on FDA news	AN
Jun. 05	US FDA clears Diasorin's Liaison Plex Yeast Blood Culture Assay	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DiaSorin S p A : receives FDA 510(k) clearance for the LIAISON PLEX® Blood Culture Yeast Assay on the new multiplexing LIAISON PLEX®	Jun. 04	PU
DiaSorin S p A : receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2	May. 16	PU
DiaSorin S p A : submits LIAISON PLEX® Yeast Blood Culture Assay for the LIAISON PLEX® system to the U.S. FDA	Mar. 13	PU
Diasorin unveils its new Corporate identity and launches the new Group website: www.diasorin.com	23-10-23	PU
DiaSorin S p A : Half-Year Financial Report at June 30, 2023	23-08-02	PU
DiaSorin S p A : Presentazione Risultati H1 2023	23-07-27	PU
DiaSorin S p A : launches the LIAISON® Legionella Urinary Ag assay in all countries accepting the CE Mark to improve diagnosis of legionnaires’ disease	23-07-17	PU
DiaSorin S p A : launches the LIAISON® B·R·A·H·M·S MR-proADM™ assay in all countries accepting the CE Mark	23-06-13	PU
DiaSorin S p A : CONSOLIDATES STRATEGIC PARTNERSHIP WITH MEMED BY SIGNING AN AGREEMENT TO DISTRIBUTE MEMED BV® TEST FOR THE ITALIAN MARKET ON THE MEMED KEY® POINT-OF-NEED PLATFORM	23-05-25	PU
DiaSorin S p A : Presentazione Risultati Q1 2023	23-05-09	PU
DiaSorin S p A : Annual Financial Report at December 31, 2022	23-04-28	PU
DiaSorin S p A : Presentazione Risultati FY 2022	23-03-27	PU
DiaSorin S p A : Simplexa® cCMV Direct assay received U.S. FDA 510(K) clearance	22-11-09	PU
DiaSorin S p A : - 9M 2022 results presentation	22-10-27	PU
DiaSorin S p A : - Presentazione risultati primi 9 mesi 2022	22-10-27	PU
DiaSorin S p A : furthers its collaboration with BARDA for the LIAISON NES	22-10-05	PU
DiaSorin S p A : Roadshows Presentation -Settembre 2022	22-09-13	PU
DiaSorin S p A : Half-Year Financial Report at June 30, 2022	22-08-09	PU
DiaSorin S p A : Strong revenues growth in the First Half of 2022 - Full Year 2022 Guidance on both Revenues and Profitability revised upwards	22-08-03	PU
DiaSorin S p A : risultati H1 2022	22-08-03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DIASORIN : Markets hailed the Q1 beat; guidance re-affirmed

May 13, 2024 at 09:36 am EDT